Jennison Associates
DYN icon

Jennison Associates’s Dyne Therapeutics DYN Stock Holding History

Jennison Associates’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,211,915
Closed -$28.6M – 589
2024
Q4 		$28.6M Sell
1,211,915
-135,037
-10% -$3.99M 0.02% 304
2024
Q3 		$48.4M Buy
1,346,952
+19,730
+1% +$785K 0.03% 234
2024
Q2 		$46.8M Buy
1,327,222
+119,671
+10% +$3.48M 0.03% 218
2024
Q1 		$34.3M Buy
1,207,551
+1,004,680
+495% +$22.7M 0.02% 277
2023
Q4 		$2.7M Buy
+202,871
New +$1.98M ﹤0.01% 444

Other funds holding DYN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return